Circular RNAs in Cardiovascular Diseases: From Regulatory Networks to Functional Effectors
International Journal of Molecular Sciences · 16.06.2026 · 27 (12) · 5418
DOI: 10.3390/ijms27125418 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 16.06.2026. Verfasst von Camilo Rebolledo und 1 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Biología Molecular y Farmacogenética, Departamento de Ciencias Básicas, Facultad de Medicina, Universidad de La Frontera, Temuco 4811230, C…. Hauptthemen laut MEDLINE: RNA, Circular, Cardiovascular Diseases, Gene Regulatory Networks. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidad de La Frontera.
Abstract (Originalsprache)
Circular RNAs have emerged as important regulators of gene expression in cardiovascular disease, expanding the current understanding of the molecular mechanisms that underlie cardiac remodeling and dysfunction. Initially regarded as byproducts of aberrant splicing, circRNAs are now recognized as stable, abundant, and functionally versatile molecules with marked tissue specificity and diverse modes of action. In the cardiovascular system, circRNAs are generated through tightly regulated back-splicing mechanisms and act through multiple molecular pathways, including microRNA sequestration, protein scaffolding, modulation of transcription and splicing, regulation of mitochondrial and metabolic homeostasis, and in some cases, peptide translation. These properties position circRNAs as regulatory hubs that connect molecular interactions to functional cellular outcomes. Across a broad range of cardiovascular conditions, including heart failure, myocardial ischemia, fibrosis, arrhythmias, cardiotoxicity, and cardiorenal syndrome, circRNAs have been implicated in processes such as hypertrophy, inflammation, cell death, extracellular matrix remodeling, and regenerative responses. Beyond their mechanistic relevance, circRNAs also hold preclinical relevance as circulating biomarkers and therapeutic targets owing to their stability in biofluids and their capacity to modulate disease-relevant networks. Nevertheless, major challenges remain, including incomplete functional validation, methodological heterogeneity, annotation inconsistencies, and barriers to clinical translation. In this review, we synthesize the current knowledge on circRNA biogenesis, molecular function, disease-specific roles, biomarker potential, and therapeutic applications and discuss the conceptual and technical advances required to move the field from descriptive association toward mechanistic and clinical impact.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centro de Biología Molecular y Farmacogenética, Departamento de Ciencias Básicas, Facultad de Medicina, Universidad de La Frontera, Temuco 4811230, Chile.
ORCID-Profile: Camilo Rebolledo, Luis A Salazar
Förderung
- Universidad de La Frontera
Zitieren
APA
Rebolledo, C., & Salazar, L. A. (2026). Circular RNAs in Cardiovascular Diseases: From Regulatory Networks to Functional Effectors. International Journal of Molecular Sciences, 27(12), 5418. https://doi.org/10.3390/ijms27125418
Vancouver
Rebolledo C, Salazar LA. Circular RNAs in Cardiovascular Diseases: From Regulatory Networks to Functional Effectors. International Journal of Molecular Sciences. 2026;27(12):5418. doi:10.3390/ijms27125418
BibTeX
@article{Rebolledo2026,
author = {Rebolledo, Camilo and Salazar, Luis A},
title = {Circular RNAs in Cardiovascular Diseases: From Regulatory Networks to Functional Effectors},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {12},
pages = {5418},
doi = {10.3390/ijms27125418}
}
EUVIMED